Core Viewpoint - NVR, Inc. has experienced significant underperformance in its stock price compared to the broader market and home construction sector, despite reporting better-than-expected earnings and revenue in Q3 2023 [2][4]. Company Overview - NVR, Inc. is a homebuilder based in Reston, Virginia, with a market capitalization of $20.6 billion, specializing in single-family homes, townhomes, and condominiums under various trade names [1]. Stock Performance - Over the past year, NVR's stock has declined by 19.4%, while the S&P 500 Index has increased by nearly 11% [2]. - Year-to-date in 2025, NVR's stock is down 11.2%, contrasting with a 14% rise in the S&P 500 [2]. - Compared to the iShares U.S. Home Construction ETF, which has declined by about 18.6% over the past year, NVR's performance remains weak [3]. Q3 Financial Results - In Q3 2023, NVR reported earnings per share (EPS) of $112.33, exceeding Wall Street's expectations of $107.88 [4]. - The company's revenue for the quarter was $2.6 billion, surpassing the forecast of $2.4 billion [4]. Earnings Forecast - Analysts predict a 16.8% decline in NVR's EPS for the current fiscal year, estimating it to be $421.69 on a diluted basis [5]. - NVR has a mixed earnings surprise history, beating consensus estimates in three of the last four quarters [5]. Analyst Ratings - Among seven analysts covering NVR, the consensus rating is "Hold," consisting of one "Strong Buy," five "Holds," and one "Strong Sell" [5]. - Michael Rehaut from JPMorgan Chase & Co. maintains a "Hold" rating with a price target of $7,900, indicating an 8.8% potential upside [6]. - The mean price target is $8,566.67, suggesting a 17.9% premium to current price levels, while the highest target of $9,300 indicates a potential upside of 28% [6].

Core Viewpoint - Everest Group, Ltd. has significantly underperformed the market and sector, with stock prices declining sharply following disappointing quarterly results, raising concerns about its growth prospects and earnings reliability [2][4][5]. Company Performance - Everest Group's stock has dropped 20.3% over the past 52 weeks and 14.5% year-to-date, contrasting with the S&P 500 Index's 12% returns and 14% surge in 2025 [2]. - The company's stock fell 11.4% in a single trading session after the release of Q3 results, which showed a modest topline increase of 79 basis points year-over-year to $4.3 billion, missing expectations by 2.9% [4]. - Net operating income per share decreased by 48.4% year-over-year to $7.54, falling short of consensus estimates by 43.7% [4]. Earnings Expectations - For the full fiscal year 2025, analysts project an adjusted EPS of $45.02, reflecting a 50.9% year-over-year increase, although the company has a history of disappointing earnings surprises [5]. - Everest has only surpassed bottom-line estimates once in the past four quarters, missing projections on three occasions [5]. Analyst Ratings - Among 18 analysts covering Everest Group, the consensus rating is a "Moderate Buy," consisting of five "Strong Buys," two "Moderate Buys," ten "Holds," and one "Strong Sell" [6]. - The mean price target for Everest Group is $368.53, indicating an 18.9% premium to current price levels, while the highest target of $446 suggests a potential upside of 43.9% [7].

Core Insights - Tyler Technologies, Inc. provides integrated software services for government entities, enhancing operational efficiency and transparency with a market cap of $20.3 billion and over 40,000 installations across nearly 13,000 locations [1] Financial Performance - Tyler's stock has underperformed the broader market, with a decline of 25.6% over the past 52 weeks and 21.4% year-to-date, while the S&P 500 Index has returned 12% and 14% respectively [2] - The company also lagged behind the Technology Select Sector SPDR Fund, which saw a 19.7% increase over the past year and 20.3% year-to-date [3] - Following the Q3 results released on October 29, Tyler's topline grew 9.7% year-over-year to $595.9 million, exceeding expectations by 19 basis points, with adjusted EPS rising 17.9% year-over-year to $2.97, also beating consensus estimates [4] Future Projections - For the full fiscal year 2025, analysts project an adjusted EPS of $8.76, reflecting a 15.6% year-over-year increase, with a strong earnings surprise history over the past four quarters [5] - The consensus rating among 18 analysts is a "Moderate Buy," consisting of 12 "Strong Buys," one "Moderate Buy," and five "Holds" [5] Analyst Ratings - On October 31, Evercore ISI analyst Kirk Materne maintained an "In-Line" rating but reduced the price target from $595 to $575, while the mean price target of $648.25 indicates a 43.1% premium to current levels, and the highest target of $800 suggests a potential upside of 76.7% [7]

Core Insights - Chipotle Mexican Grill, Inc. has significantly underperformed the broader market, with stock prices dropping 47.6% year-to-date and 47.3% over the past 52 weeks, while the S&P 500 Index gained 12.3% in 2025 and 11% over the past year [2][4] - The company's Q3 results revealed a 7.5% year-over-year increase in topline revenue to $3 billion, which fell short of market expectations by 48 basis points, and an adjusted EPS of $0.29, which was a slight increase of 2 cents from the previous year [4][5] - Analysts maintain a consensus rating of "Moderate Buy" for CMG stock, with a mean price target of $44.39, indicating a 40.3% premium to current price levels, and a street-high target of $70 suggesting a potential upside of 121.3% [6][7] Financial Performance - For the full fiscal year 2025, analysts project an adjusted EPS of $1.16, reflecting a year-over-year increase of 3.6% [5] - The company has a history of earnings surprises, having exceeded bottom-line estimates in each of the past four quarters [5] Analyst Ratings - Among 33 analysts covering CMG, there are 21 "Strong Buys," three "Moderate Buys," eight "Holds," and one "Strong Sell," indicating a slightly less optimistic outlook compared to the previous month [6][7] - JP Morgan analyst John Ivankoe has maintained a "Neutral" rating but lowered the price target from $44 to $40 [7]

Core Insights - Gartner, Inc. is valued at a market cap of $16.2 billion and operates through Research, Conferences, and Consulting segments to support leaders across various industries [1] Stock Performance - Gartner's shares have significantly underperformed the broader market, dropping 56.7% over the past 52 weeks, while the S&P 500 Index has risen 10.5% [2] - Year-to-date, Gartner's shares have decreased by 53.7%, compared to an 11.2% gain in the S&P 500 [2] - The company's stock has also lagged behind the Technology Select Sector SPDR Fund, which increased by 17.8% over the same period [3] Financial Performance - In Q3 2025, Gartner reported adjusted EPS of $2.76, which beat estimates, and revenue of $1.52 billion, meeting forecasts [4] - Despite the positive earnings report, shares fell 7.6% due to weaknesses in operating segments, including a 3.2% decline in Consulting revenue and a 1.6% decline in Conferences revenue, along with negative free cash flow of $269 million [4] Future Earnings Expectations - For the fiscal year ending December 2025, analysts expect Gartner's adjusted EPS to decline by 9.2% year-over-year to $12.79 [5] - Gartner has a promising earnings surprise history, having beaten consensus estimates in the last four quarters [5] - The consensus rating among 14 analysts covering the stock is a "Moderate Buy," with four "Strong Buy" ratings, nine "Holds," and one "Strong Sell" [5] Price Target Adjustments - On November 5, Barclays cut its price target on Gartner to $260 while maintaining an "Equal Weight" rating [6] - The mean price target of $278.18 represents a 24.1% premium to Gartner's current price levels [6] - The highest price target of $390 suggests a potential upside of 74% [6]

Core Insights - Broadridge Financial Solutions, Inc. has a market capitalization of $26.4 billion and operates in investor communications and technology solutions for the financial services industry [1] Performance Overview - Broadridge has underperformed the broader market, with stock prices showing a marginal increase of 0.77% over the past 52 weeks and 0.46% gains in 2025, compared to the S&P 500 Index's 10.5% gains over the past year and 11.2% returns in 2025 [2] - The company also lagged behind the Technology Select Sector SPDR Fund, which surged 17.8% over the past 52 weeks and 17% year-to-date [3] Financial Results - Broadridge reported better-than-expected Q1 results on November 4, with a year-over-year revenue increase of 11.7% to $1.6 billion, exceeding expectations by 3.6% [4] - Adjusted EPS for the quarter soared 51% year-over-year to $1.51, surpassing consensus estimates by 26.9% [4] Future Projections - For the full fiscal 2026, analysts expect Broadridge to deliver an adjusted EPS of $9.38, reflecting a 9.7% year-over-year increase [5] - The company has a strong earnings surprise history, having exceeded bottom-line projections in each of the past four quarters [5] Analyst Ratings - Among nine analysts covering Broadridge, the consensus rating is a "Hold," consisting of three "Moderate Buys" and six "Holds" [5] - UBS analyst Alex Kramm reiterated a "Neutral" rating on Broadridge, lowering the price target from $280 to $250, while the mean price target of $266.43 suggests a 17.3% premium to current price levels [7] - The street-high target of $305 indicates a potential upside of 34.3% [7]

Core Insights - Charles River Laboratories International, Inc. (CRL) is a contract research organization with a market cap of approximately $8 billion, providing drug discovery, non-clinical development, and safety testing services [1] Financial Performance - CRL's stock has underperformed the broader market, declining 13.7% over the past 52 weeks and 12.2% year-to-date, while the S&P 500 Index gained 10.5% over the same period [2] - The company's stock prices dropped 5.7% following the release of its Q3 results, where the topline dipped 49 basis points year-over-year to $1 billion, but exceeded expectations by 2.1% [4] - Adjusted EPS for Q3 declined 6.2% year-over-year to $2.43, surpassing consensus estimates by 4.7% [4] - For the full fiscal 2025, analysts expect CRL to deliver an adjusted EPS of $10.21, down 1.1% year-over-year [5] Analyst Ratings and Price Targets - Among 16 analysts covering CRL, the consensus rating is a "Moderate Buy," with 10 "Strong Buys" and six "Holds" [5] - Morgan Stanley analyst Ricky Goldwasser maintained an "Equal-Weight" rating and raised the price target from $170 to $185, with a mean price target of $192.93 representing a 19% premium to current price levels [7] - The street-high target of $211 suggests a notable 30.2% upside potential [7]

Core Insights - Henry Schein, Inc. (HSIC) has a market capitalization of $8.4 billion and is a prominent global provider of healthcare products and services, primarily catering to dental and medical practitioners [1] - The company has experienced stock underperformance compared to the broader market, with a 7.4% increase in HSIC shares over the past 52 weeks, while the S&P 500 Index rose by 13.2% [2] - HSIC shares surged 10.8% following the announcement of third-quarter earnings that exceeded market expectations, with revenue of $3.34 billion, reflecting a year-over-year increase of 5.2% [4] Financial Performance - The company reported a non-GAAP EPS increase of 13.1% to $1.38, and adjusted EBITDA reached $295 million, up from $268 million in the previous year [5] - Management has raised its full-year 2025 non-GAAP EPS outlook to a range of $4.88–$4.96, anticipating sales growth of 3–4% [5] - Analysts project HSIC's adjusted EPS to grow 3.6% year-over-year to $4.91 for the fiscal year ending in December 2025 [6] Analyst Ratings - Among 15 analysts covering HSIC, the consensus rating is a "Moderate Buy," consisting of five "Strong Buy" ratings, nine "Holds," and one "Strong Sell" [6] - The current analyst configuration is more bullish than three months ago, with four "Strong Buy" ratings on the stock [7] - Leerink Partners analyst Michael Cherny reaffirmed a "Hold" rating on HSIC with a price target of $71 [7]

Core Insights - Intuit Inc. has underperformed the broader market and sector over the past year, with stock prices gaining only 5.4% year-to-date and declining 5.5% over the past 52 weeks, while the S&P 500 Index and Technology Select Sector SPDR Fund saw gains of 14.5% and 23.9% respectively [2][3] Financial Performance - In Q4, Intuit reported a 20.3% year-over-year increase in revenue to $3.8 billion, exceeding expectations by 2.3%. Adjusted EPS surged 38.2% year-over-year to $2.75, surpassing consensus estimates [4] - For the full fiscal 2026, analysts expect an adjusted EPS of $23.17, reflecting a 15% year-over-year increase. Intuit has a strong earnings surprise history, having exceeded bottom-line estimates in the past four quarters [5] Analyst Ratings and Price Targets - Among 29 analysts covering Intuit, the consensus rating is a "Strong Buy," with 20 "Strong Buys," three "Moderate Buys," five "Holds," and one "Strong Sell." This is a slight decrease from three months ago when 21 analysts recommended "Strong Buy" [5][6] - Morgan Stanley analyst Keith Weiss maintained an "Overweight" rating but lowered the price target from $900 to $880. The mean price target of $835.46 suggests a 26.1% premium to current price levels, while the highest target of $971 indicates a potential upside of 46.6% [6]

Core Insights - Jabil Inc. has shown significant stock performance, outperforming both the broader market and sector indices over the past year [2][3] - Despite strong financial results, Jabil's stock experienced a decline following its Q4 earnings release, but rebounded in subsequent trading [4] - Analysts maintain a positive outlook on Jabil, with a consensus rating of "Strong Buy" and an upward revision of price targets [5][6] Financial Performance - Jabil's Q4 revenue increased by 18.5% year-over-year to $8.3 billion, exceeding expectations by 7.7% [4] - Adjusted EPS for Q4 grew by 43% year-over-year to $3.29, beating consensus estimates by 11% [4] - For fiscal 2026, analysts project an adjusted EPS of $10.11, reflecting a 13.7% year-over-year increase [5] Stock Performance - Jabil's stock price has increased by 40.3% year-to-date and 56.4% over the past 52 weeks, significantly outperforming the S&P 500 Index [2] - The stock also outperformed the Technology Select Sector SPDR Fund, which saw a 23.9% increase year-to-date [3] Analyst Ratings - The consensus rating among analysts is a "Strong Buy," with eight "Strong Buys" and two "Holds" [5] - Barclays analyst Tim Long raised the price target for Jabil from $223 to $267, indicating a potential upside of 32.3% based on the street-high target [6]